Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 25 Neoplasms 13 Carcinoma, Non-Small-Cell Lung 13 Breast Neoplasms 13 Colonic Neoplasms 9 Uterine Cervical Neoplasms 7 Lung Neoplasms 6 Colorectal Neoplasms 6 Urinary Bladder Neoplasms 5 Melanoma 5 Leukemia, Myeloid, Acute 5 Carcinoma, Renal Cell 5 Uterine Cervical Dysplasia 4 Lymphoma, Large B-Cell, Diffuse 4 Esophageal Neoplasms 4 Brain Neoplasms 4 Thrombocythemia, Essential 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Polycythemia Vera 3 Papillomavirus Infections 3 Oropharyngeal Neoplasms 3 Neuroblastoma 3 Mouth Neoplasms 3 Liver Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Glioma 3 Gallbladder Neoplasms 3 Carcinoma, Hepatocellular 3

Interventions

Ipilimumab 29 Nivolumab 23 pembrolizumab 14 incomplete Freund's adjuvant 10 Cyclophosphamide 10 Melphalan 9 Interleukin-2 9 CTLA-4 Antigen 8 tebentafusp 7 sargramostim 7 Temozolomide 7 MART-1 Antigen 7 Dacarbazine 7 Ranibizumab 6 montanide ISA 51 5 fludarabine phosphate 5 fludarabine 5 Sunitinib 5 Radiosurgery 5 Carboplatin 5 Blood Specimen Collection 5 Bevacizumab 5 aldesleukin 4 aflibercept 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Biopsy 4 trametinib 3 sotrastaurin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Watchful Waiting × Clear all

NCT07338968 2026-01-14

CoMpass

Aura Biosciences

Not yet recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡